Group 1 - The company, 精锋医疗-B (02675), announced that the overall coordinator has fully exercised the over-allotment option, involving a total of 4.1583 million H shares, which accounts for approximately 15% of the total shares available for subscription under the global offering before any over-allotment options are exercised [1] - The over-allotment shares will be issued at a price of HKD 43.24 per H share, aimed at expediting the delivery of H shares to relevant subscribers who agreed to subscribe under the global offering [1] - The stabilization period for the global offering ended on February 4, 2026, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1] Group 2 - During the stabilization period, the stabilization agent did not buy or sell any H shares in the market to stabilize the price [2]

Core Viewpoint - The company, Zhihui (02513), announced that the underwriter and overall coordinator has fully exercised the over-allotment option as of February 4, 2026, involving a total of 5.6129 million H-shares, which accounts for approximately 15% of the total shares available for subscription under the global offering before any over-allotment options are exercised [1] Group 1 - The over-allotment shares will be issued and allocated by the company at a price of HKD 116.20 per H-share [1] - The over-allotment shares will be used to facilitate the delivery of relevant H-shares to subscribers who agreed to delay the delivery of their subscribed shares under the global offering [1] - The stabilization period for the global offering will end on February 4, 2026, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1]

Core Viewpoint - Naxin Micro (02676) has partially exercised the over-allotment option as of January 2, 2026, involving a total of 1.0266 million H-shares, which represents approximately 5.38% of the total shares available for subscription before the exercise of the over-allotment option [1][1]. Group 1 - The over-allotment shares will be issued at a price of HKD 116.00 per H-share, which is the same as the offering price for the global sale [1][1]. - The stabilization period for the global offering ended on January 2, 2026, which is 30 days after the deadline for submitting applications for the Hong Kong public offering [1][1].

Group 1 - The company, Quantitative Group (02685), announced that the overall coordinator partially exercised the over-allotment option on December 24, 2025, involving a total of 1.75 million shares, which represents approximately 13.11% of the total number of shares initially available for subscription under the global offering before the exercise of any over-allotment option [1] - The over-allotment shares will be issued and allocated by the company at a price of HKD 9.80 per share [1] - The over-allotment shares will be used to facilitate the return of 1.75 million shares borrowed under a stock borrowing agreement to Mars Legend Limited, which were used to cover the over-allocation under the international offering [1] Group 2 - The company announced that the stabilization period for the global offering ended on December 24, 2025, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1]

Group 1 - The company announced the partial exercise of the over-allotment option, involving a total of 1,750,000 shares, which represents approximately 13.11% of the initial shares available for subscription before the exercise of any over-allotment option [1] - The over-allotted shares will be issued at a price of HKD 9.80 per share, excluding various fees, which is the same as the global offering price per share [1] - The over-allotted shares will be used to facilitate the return of 1,750,000 shares borrowed under a stock borrowing agreement to Mars Legend Limited [1] Group 2 - The stabilization period for the global offering ended on December 24, 2025, which is the 30th day after the deadline for submitting applications for the Hong Kong public offering [1]

Core Viewpoint - The company LeShuShi (02698) has exercised its overallotment option, resulting in the issuance of 13.6326 million shares, which represents approximately 15% of the total shares available for the global offering before the exercise of the overallotment option [1] Group 1 - The overallotment option was fully exercised by the global coordinators and international underwriters on December 5, 2025 [1] - The shares were issued at a price of HKD 26.20 per share, which is the same as the offering price for the global sale [1] - The stabilization period for the global offering ended on December 5, 2025, which is 30 days after the deadline for submitting applications for the Hong Kong public offering [1]

Core Viewpoint - Junsheng Electronics (600699) announced that the global offering's stabilization period will end on December 3, 2025, which is the 30th day after the submission deadline for the Hong Kong public offering application [1] Group 1 - The stabilization actions taken by China International Capital Hong Kong Securities Co., Ltd. and its affiliates during the stabilization period are detailed in the announcement [1] - The overall coordinator, acting on behalf of the international underwriters, did not exercise the over-allotment option during the stabilization period [1] - The over-allotment option will expire on December 3, 2025, and no H shares will be issued or are expected to be issued under this option [1]

Core Insights - Minglue Technology-W (02718) announced that the overallotment option described in the prospectus was fully exercised by the sole sponsor and global coordinator on November 27, 2025, involving a total of 1.0828 million Class A shares, which represents approximately 15% of the total shares initially available for subscription under the global offering [1] - The shares from the overallotment option will be issued at a price of HKD 141.00 per share [1] - The overallotment shares will be used to facilitate the delivery of a portion of the shares to cornerstone investors who have agreed to delay the delivery of their subscribed shares under the global offering [1] - The stabilization period for the global offering ended on November 27, 2025, which is the 30th day after the submission of the public offering application in Hong Kong [1]

Core Insights - The company, Jinfang Pharmaceutical-B (02595), announced that the sole sponsor and overall coordinator has fully exercised the over-allotment option as of October 16, 2025, involving a total of 13.386 million H-shares, which represents approximately 15% of the total shares available for subscription before the exercise of any over-allotment options [1] - The over-allotment shares will be issued at a price of HKD 20.39 per H-share and will be used to cover the excess allocation in the international offering [1] - The stabilization period for the global offering ended on October 16, 2025, which is 30 days after the submission deadline for the Hong Kong public offering application [1]

Core Viewpoint - The announcement indicates that the stabilization period for the global offering of Xunzhong Communication (02597) ended on August 3, 2025, with no over-allotment of H-shares during the international offering [1] Group 1 - The stabilization period concluded 30 days after the deadline for submitting the application for the Hong Kong public offering [1] - The overall coordinator did not exercise the over-allotment option due to the absence of excess allocation of H-shares [1] - No stabilization actions were taken during the stabilization period by the stabilization agent or any associated parties [1] Group 2 - The over-allotment option expired on August 3, 2025, meaning the company will not issue H-shares under this option [1]